Your session is about to expire
← Back to Search
mRNA-1468 for Shingles
Study Summary
This trial will measure if a vaccine is safe and triggers an immune response in people.
- Shingles
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Media Library
- Do you feel like you are healthy overall?You have not had shingles in the last 10 years.Are you available and willing to attend up to 10 in-person visits and up to 8 phone calls over a period of about 15 months?You have never received a vaccine for chickenpox or shingles.You must be 50 years old or above.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
- Group 1: mRNA-1468: Dose 4
- Group 2: Shingrix
- Group 3: mRNA-1468: Dose 1
- Group 4: mRNA-1468: Dose 3
- Group 5: mRNA-1468: Dose 2
Frequently Asked Questions
Is it still possible to enroll in this clinical experiment?
"According to clinicaltrials.gov, this study is no longer accepting patients for participation as the trial was last updated on January 18th 2023. Despite this closure of recruitment, there are still 54 other trials that require participants at present time."
To what extent does this research venture take place in our state?
"19 clinical centres are presently recruiting patients for this medical trial, including Tekton Research, Inc - Longmont Center in Longmont, Meridien Research in Lakeland and Floridian Clinical Research in Miami Lakes. There are numerous other sites involved as well."
Who else is applying?
What state do they live in?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
What site did they apply to?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
How responsive is this trial?
Most responsive sites:
- Research Works, INC: < 24 hours
Average response time
- < 2 Days
Typically responds via
Share this study with friends
Copy Link
Messenger